Becton, Dickinson and Co. | BDX - Des Atouts

Prix De L'Action
154.13
Variation Quotidienne
-2.40 -1.53%
Mensuellement
-16.39%
Annuel
-33.05%
Q1 Prévisions
149.51




Des Atouts Changement Date
Abbott USD 86.71B 2.53B 2025-12
Agilent USD 12.81B 86M 2025-12
Align Technology USD 6.23B 141K 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Avanos Medical USD 1.07B 6M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bio-Rad Laboratories USD 10.58B 880.1M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.43B 224M 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Exact Sciences USD 5.86B 39.38M 2025-12
Globus Medical USD 5.3B 207.12M 2025-12
Hologic USD 9.18B 165.8M 2025-12
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.46B 1.11B 2025-12
J&J USD 199.21B 6.39B 2025-12
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.48B 139M 2025-12
Solventum Corp USD 14.29B 321M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12